CYTOIMMUNE THERAPEUTICS
Company Overview
Social Media Profiles
About CytoImmune Therapeutics
Description
CytoImmune Therapeutics is a clinical-stage immunotherapy company focused on developing innovative therapies to harness the body's immune system against cancer. Utilizing advanced biotechnology, the company aims to provide effective treatment options for patients with various malignancies, advancing the future of cancer treatment in the biotechnology and life sciences industry.
Specialties
Off-the-shelf CAR NK cell therapy
Innovative cancer immunotherapy
NK cell engineering platform
Targeted antigen recognition
Clinical trials in oncology
Products & Services
CAR NK Cell Therapies
Immunotherapy Treatments
Biotechnology Solutions
Cancer Treatment Innovations
NK Cell Engineering Services
Contact Information
No contact information available
Competitors & Similar Companies(9)
Arcus Biosciences
California, • United States
Kite Pharma
California, • United States
Adaptimmune Therapeutics
Pennsylvania, • United States
Bluebird Bio
Massachusetts, • United States
Immunocore
Oxfordshire, • United Kingdom
Mirati Therapeutics
California, • United States
Celgene (now part of Bristol-Myers Squibb)
New York, • United States
Forty Seven Inc. (now part of Gilead Sciences)
California, • United States
Gilead Sciences
California, • United States
News & Media
Search Terms:
cytoimmune therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about CytoImmune Therapeutics
Where is CytoImmune Therapeutics located?
The headquarter of CytoImmune Therapeutics is located in Monrovia, California, United States
What is the official website of CytoImmune Therapeutics?
The official website of CytoImmune Therapeutics is https://www.cytoimmune.com
What industry does CytoImmune Therapeutics belong to?
CytoImmune Therapeutics belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of CytoImmune Therapeutics?
CytoImmune Therapeutics specializes in Off-the-shelf CAR NK cell therapy, Innovative cancer immunotherapy, NK cell engineering platform, Targeted antigen recognition, Clinical trials in oncology.
What products and services is CytoImmune Therapeutics likely to offer?
CytoImmune Therapeutics offers CAR NK Cell Therapies, Immunotherapy Treatments, Biotechnology Solutions, Cancer Treatment Innovations, NK Cell Engineering Services.
Who are the competitors of CytoImmune Therapeutics?
Competitors of CytoImmune Therapeutics are Arcus Biosciences, Kite Pharma, Adaptimmune Therapeutics, Bluebird Bio, Immunocore, Mirati Therapeutics, Celgene (now part of Bristol-Myers Squibb), Forty Seven Inc. (now part of Gilead Sciences), Gilead Sciences.
What does CytoImmune Therapeutics do?
CytoImmune Therapeutics is a clinical-stage immunotherapy company focused on developing innovative therapies to harness the body's immune system against cancer. Utilizing advanced biotechnology, the company aims to provide effective treatment options for patients with various malignancies, advancing the future of cancer treatment in the biotechnology and life sciences industry.